On behalf of SFT, ESOT and TTS
Dear Colleagues,
Preventing ischemia reperfusion injury (IRI) is to organ transplantation what the foundation is to a building. You do not see it but the solidity and the longevity of the building relies directly on it. Although the mechanisms of IRI are still not fully understood, much progress has been made in recent years. Ischemia reperfusion injury not only leads to major metabolic dysfunction but also triggers the innate immune response, which in turn provides the co-stimulation signal for adaptive immunity. It is now well established that the severity of IRI impacts on long-term graft outcome. The organ shortage, experienced in almost all countries developing organ transplant programs, requires the use of more and more extended criteria donor (ECD) organs or those retrieved from donors after cardiac death (DCD). The former are more vulnerable to IRI because of pre-existing lesions; the latter experience warm ischemia, which is an experimental model of IRI. Improving our understanding of the lesions in order to better prevent or treat them has become a major goal in the field of transplantation.
We look forward to welcoming you to the 1st IMIRT meeting.
Benoît BARROU
| | |
| Startdate: | 3-5-2012 | Enddate: | 4-5-2012 |
| Country: |
France
|
| Location: | Futuroscope, Poitiers, France |
| Organizor: | VBCE-IMIRT |
| |
| Address: | 43, rue de l'Abbé Groult 75015 Paris, France | Telephone: | 0033 145 33 60 46 |
| Telefax: | 0033 145 33 57 15 |
| Website: | www.imirt.fr |
| E-mail: | imirt@vbce.fr |
| Link: | |
| File: | IMIRT_12-1st_annoucement-V5.pdf |